ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
5 shares to profit from a weaker Australian dollar in 2019
⏸️ ASX Shares
3 quality shares to reinvest your Sydney Airport dividend into
⏸️ Investing
8 companies to profit from a falling Australian dollar in 2019
Healthcare Shares
The CSL share price has beaten the ASX 200 by 34% in 2018
Share Gainers
The ResMed Inc. share price is up 46% this year
⏸️ ASX Shares
3 blue chip ASX shares to buy this week
Share Market News
2 companies to profit from a falling Australian dollar in 2019
Share Market News
HSBC picks 10 biggest risks to markets for 2019
Growth Shares
3 fast-growing ASX healthcare shares to buy this month
Share Gainers
Why the ResMed share price is charging higher today
Share Market News
Top brokers name 3 ASX shares to buy next week
Share Market News
ASX 200 opens higher on Friday: IOOF share price plunges 30% lower
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
